Market Closed -
Other stock markets
|
After market 01:23:52 am | |||
6.75 EUR | -3.57% | 6.755 | +0.07% |
17/04 | OSE: licensing agreement with AbbVie enters into force | CF |
17/04 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.71% | 163M | |
+18.26% | 47.02B | |
+48.77% | 41.86B | |
+1.34% | 41.76B | |
-4.27% | 28.8B | |
+11.29% | 26.05B | |
-21.13% | 19.15B | |
+4.67% | 12.55B | |
+27.97% | 12.34B | |
-3.54% | 11.82B |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- Ose Immunotherapeutics, GenDx to Co-develop Diagnostic Test Companion for Cancer Vaccine Trial